ESR1 and breast cancer: ESR1 and PGR promoters are subjected to cyclic methylation/demethylation of CpG dinucleotides, which, in turn, can modulate ERα and PgR levels and the biological signaling downstream of ERα/PgR in human HR+ BC cells [35,36,37,38].